Drug intelligence / Profile preview

iodine I-131 gamma globulin

Development stage
Unknown
Modality
Beta Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Alpha Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Iodine I-131 gamma globulin is a radiopharmaceutical consisting of human gamma globulin labeled with the radioisotope iodine-131. It is primarily used as a diagnostic tracer in clinical research to evaluate the metabolism, distribution, and catabolic rates of immune proteins in various disease states. By measuring the radioactivity in blood and urine over time, researchers can calculate the catabolic half-life and distribution space of the protein. Historically, it has been employed to study protein turnover in conditions such as amyloidosis, rheumatoid arthritis, and the nephrotic syndrome, providing insights into how these diseases alter the body's handling of gamma globulins.

Other names
I-131 labeled human gamma globulinI131 labeled human gamma globulinI 131 labeled human gamma globuliniodinated gamma globulinI-131 labeled normal human gamma globulinI131 labeled normal human gamma globulinI 131 labeled normal human gamma globulinI-131 labeled y-globulinI131 labeled y-globulinI 131 labeled y-globulin

Beyond the preview

Go deeper on iodine I-131 gamma globulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iodine I-131 gamma globulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call